Belpointe Asset Management’s Tenaya Therapeutics TNYA Stock Holding History

Belpointe Asset Management’s Portfolio TNYA Stock Details TNYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$26K	Buy	+37,509	New	+$27.7K	﹤0.01%	1060

Other funds holding TNYA

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

EAM

Empery Asset Management New York $83M AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BGM

Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $141M AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Belpointe Asset Management's TNYA Position: Q1 2026 in Review

Belpointe Asset Management opened a new position in Tenaya Therapeutics (TNYA) in Q1 2026: 37,509 shares worth $26K. The stake represents ﹤0.01% of the portfolio and ranks #1060 among its holdings.

103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.

Belpointe Asset Management held 37,509 shares of Tenaya Therapeutics worth $26K as of Q1 2026.
Tenaya Therapeutics was a new Belpointe Asset Management position in Q1 2026.
Tenaya Therapeutics made up ﹤0.01% of Belpointe Asset Management's portfolio in Q1 2026, its #1060 holding.
103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.

Based on Belpointe Asset Management's 13F filing for Q1 2026, filed 28 Apr 2026.